Français
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
coronavirus infections/hypoxie
Le lien est enregistré dans le presse-papiers
Page 1 de 98 résultats
N-terminal Pro B-type Natriuretic Peptide and Vitamin D Levels as Prognostic Markers in COVID-19 Pneumonia
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
On 30 January 2020, World Health Organization (WHO) officially declared the COVID-19 epidemic as a public health emergency of international concern. An acute respiratory disease, caused by a novel coronavirus (SARS-CoV-2, previously known as 2019-nCoV), the coronavirus disease 2019 (COVID-19) has
Complementary Intervention for COVID-19
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
Since last December 2019, a syndrome of severe pneumonia associated with the coronavirus disease 2019 (COVID-19) emerged in Wuhan, Hubei Province, China. It is highly contagious and rapidly spread to many other parts of China and almost all countries all over the world, representing one of the most
Therapeutic Plasma Exchange (TPE) for Covid-19 Cytokine Release Storm (CRS)
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
PROTOCOL SUMMARY:
Long title: Proposed use of TPE (therapeutic plasma exchange), to Limit Coronavirus Associated Complications: An Open label, Phase 2 Study
Clinical Phase: Two arms, Phase 2 Open Label
Conducted by: Department of Pulmonology and Critical Care; Pak Emirates Military Hospital.
Sample
Hyperbaric Oxygen as an Adjuvant Treatment for Patients With Covid-19 Severe Hypoxemia
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
Nitric Oxide Therapy for COVID-19 Patients With Oxygen Requirement
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
Coronavirus disease 2019 (COVID-19) consists mainly of a respiratory infection that spans from a mild involvement of the upper respiratory tract to severe pneumonia leading to respiratory distress, shock, and death. Fever, cough, and dyspnea/tachypnea, together with myalgia and fatigue, have been
Relation Between Lab Finding and COVID-19 Severity
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
. Conavirus belongs to the subfamily of Ortho-coronavirinae in the family of Coronaviridae and the Order Nidovirales. In 2003, a SARS-CoV had caused the out- break of severe acute respiratory syndrome. In December 2019, an "unknown viral pneumonia" out- break has been reported. Finally, a novel
Early Cognitive Assessment and Evolutionary Monitoring of Patients With Severe ARDS on COVID-19 Pneumonia Requiring Mechanical Ventilation
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
Hypertonic Saline for COVID-19 Symptoms
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
Since its emergence as severe outbreak in China in December 2019, coronavirus disease 2019 (COVID-19) has spread so rapidly in the world that more than 780,000 cases have so far been reported worldwide and since then the WHO has declared it as a pandemic. The rapid spread of the disease is imposing
RLF-100 (Aviptadil) Intermediate Population Expanded Access Protocol (SAMICARE)
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
5. INTRODUCTION
5.1 Executive Summary RLF-100 (aviptadil) is a synthetic form of Vasoactive Intestinal Polypeptide (VIP), a ubiquitous, naturally synthesized human peptide with extensively documented anti-inflammatory, anti-cytokine cascade properties. It has been granted FDA Fast Track Designation
Use of Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Caused by COVID-19
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
A Study of Mesenchymal Stem Cells as a treatment in Patients with Acute Respiratory Distress Syndrome caused by COVID-19 is a pilot phase, open label, non-randomized study, with a single study center.
The current pandemic caused by the novel virus SARS-CoV-2 has lead to a health care crisis
The PAWS-COVID-19 (Pediatric AirWay complicationS COVID-19) Registry
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
GlitazOne Treatment for Coronavirus HypoxiA, a Safety and Tolerability Open Label With Matching Cohort Pilot Study
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
Effectiveness of Convalescent Immune Plasma Therapy
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
The aim of the study is to evaluate the safety, improvement of clinical symptoms with hypoxemia, metabolic and laboratory parameters of patients with convalescent immune plasma treatment in severe Covid-19 patients followed up in critical care unit.
The Utility of Camostat Mesylate in Patients With COVID-19 Associated Coagulopathy (CAC) and Cardiovascular Complications
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
The trial is in-patient only. Participants are identified by the hospital physicians and house staff, and contacted by research study personnel. Potential participants fulfilling inclusion criteria and not fulfilling exclusion criteria who agree to participate and sign the informed consent undergo
PROSAIC-19 - Prospective Longitudinal Assessment in a COVID-19 Infected Cohort
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
INTRODUCTION
1.1 BACKGROUND
Coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 infection is a new rapidly spreading infectious disease with no proven treatment options. The virus causes a spectrum of disease ranging from mild coryzal symptoms to severe respiratory compromise requiring
La base de données d'herbes médicinales la plus complète soutenue par la science
- Fonctionne en 55 langues
- Cures à base de plantes soutenues par la science
- Reconnaissance des herbes par image
- Carte GPS interactive - étiquetez les herbes sur place (à venir)
- Lisez les publications scientifiques liées à votre recherche
- Rechercher les herbes médicinales par leurs effets
- Organisez vos intérêts et restez à jour avec les nouvelles recherches, essais cliniques et brevets
Tapez un symptôme ou une maladie et lisez des informations sur les herbes qui pourraient aider, tapez une herbe et voyez les maladies et symptômes contre lesquels elle est utilisée.
* Toutes les informations sont basées sur des recherches scientifiques publiées
